BOLD
Boundless BioCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade C from latest DB weights. Momentum 40.5 / Value 57.9
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-03.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
40
Value
58
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Earnings
2026-11-03
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-28 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-28
Investment thesis
As of 2026-10-28
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $4.00
Why
Momentum40 · Δ7d -
Value58 · Δ7d -0.0
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-03.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-11-03
Lead driver: Value · See fundamentals
Momentum
40
15% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
85% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 40.5 / Value 57.9
Fundamentals (TTM)As of 2026-10-28
Fundamentals (TTM)
As of 2026-10-28
Market Cap
$56.87M
Beta
-
Shares Out
22.75M
P/E (TTM) · Derived
-1.0
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.99
Rev YoY
-
EPS YoY
+50.5%
Gross Margin
-
Op Margin
-
Net Debt
-$58.55M
Current Ratio
9.48
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data